Cancer Clinical Trial
— PALPHA-1Official title:
Assessment of the Reasons for Accepting or Refusing Early Palliative Care by the Patients Included in an Early Phase Clinical Trial
Verified date | July 2023 |
Source | Centre Leon Berard |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a prospective, multicentre study, considered as " non-RIPH ("Recherche n'Impliquant pas la Personne Humaine - Research that does not involve humans ". Indeed, the patient's participation in the study and the completion of the various questionnaires has no impact on patient's safety and is not likely to change patients' management. Patients accepting to take part to an early phase trial will be proposed to participate in the PALPHA-1 trial. They can accept or refuse to have palliative supportive care. The main objective of this study is to assess the reasons for accepting and refusing early palliative care in patients included in an early phase clinical trial. The secondary objectives will enable to describe and analyze the number (effective) and the rate (%) of acceptance and/or refusal of early palliative support, to assess patients' understanding and perception of the " combined " management by comparing the semantic content of the patient-investigator ecological interaction during the proposal for inclusion in the trial (i.e. what was explicitly said), with that of the semi-structured post-consultation inclusion interviews ( ie what the patients understood, perceived), to compare the quality of life and the anxiety-depression of patients according to their acceptance or refusal of the mixed care at the inclusion and at the end of the early phase trial, to compare the clinical, medical and socio-demographic characteristics of the patients, the overall survival of patients according to their acceptance or refusal of the combined management and finally for the patients accepting the Palliative Care Management (PCM), to describe throughout the study, the patients' compliance to palliative supportive care undertaken.
Status | Completed |
Enrollment | 37 |
Est. completion date | March 22, 2023 |
Est. primary completion date | March 22, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age over 18 - Patient included in an early phase clinical trial - Patient who has not been taken in charge for palliative care - Life expectancy of at least 16 weeks - Patient not opposed to data's collection and processing for the study - Patient affiliated to a social security system Exclusion Criteria: - Patient unable to read/understand the French language - Patient with psychological disability (e.g. too great vulnerability, psychiatric disorder) or physical disability (e.g. physical / motor disability) - Patients under autorship, curators or legal protection, - Patients already participating in a clinical trial or interventional study related to supportive care. |
Country | Name | City | State |
---|---|---|---|
France | Centre Leon Berard | Lyon |
Lead Sponsor | Collaborator |
---|---|
Centre Leon Berard |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the reasons for accepting / refusing early palliative care in patients included in an early phase clinical trial | Thematic content analysis of semi-directive qualitative interviews | At baseline | |
Secondary | Description and analysis of the number (effective) of acceptance of early palliative support | Numbers of acceptance of the early palliative care management for all patients seen in early phase unit consultation | At baseline | |
Secondary | Description and analysis of the percentage of acceptance of early palliative support | Percentages of acceptance of the early palliative care management for all patients seen in early phase unit consultation | At baseline | |
Secondary | Assessment of patients' understanding and perception of the early palliative care management | Comparison of qualitative semantic content of patient-investigator interaction with the semi-directive post-consultation inclusion interview | At baseline | |
Secondary | Comparison of the quality of life of patients according to their acceptance or refusal of the mixed care | Quality of life evaluated with the FACT-G7 (Functional Assessment of Cancer Therapy - General - 7-item version) questionnaire (range from 0 (better outcome) to 28 (worse outcome) | Up to 24 months | |
Secondary | Comparison of the anxiety-depression of patients according to their acceptance or refusal of the mixed care | Anxiety-depression evaluated with the HADS (Hospital Anxiety and Depression Scale) questionnaire (range 0-7: No symptoms, range 8-10: Doubtful symptoms, range >=11: Symptoms of anxiety or depression) | Up to 24 months | |
Secondary | Comparison of the clinical, medical and socio-demographic characteristics of patients for the patients accepting the palliative care management | Using PALLIA 10 scale (PALLIAtive scale composed of 10 items, minimum value: 1, maximum value: 10. A specialized advice in palliative care is required if score > 3) | At baseline | |
Secondary | Comparison of the clinical, medical and socio-demographic characteristics of patients who accept or refuse the palliative care management | Using PRONOPALL score (Prognostic overall survival score). Range 0-3: Favorable overall survival score, Range 4-7: Intermediate overall survival score, Range 8-10: Unfavorable overall survival score. | At baseline | |
Secondary | Comparison of the clinical characteristics of patients who accept or refuse the palliative care management | Clinical symptoms evaluated using ESAS (Edmonton Symptom Assessment System) questionnaire (range from 0 (better outcome) to 10 (worse outcome)) | At baseline | |
Secondary | Comparison of the socio-demographic characteristics of patients who accept or refuse the palliative care management | Patients' characteristics (Age, sex, family situation, place of residence, socio-educational level, professional activity) | At baseline | |
Secondary | Comparison of the medical characteristics of patients who accept or refuse the palliative care management | Patients' medical history: Treatments | Up to 24 months | |
Secondary | Comparison of the medical characteristics of patients who accept or refuse the palliative care management | Patients' medical history: Use of specialists' consultations (e.g. intensive care unit, emergency hospitalization, palliative care unit, number/types of consultations, pain, nutrition) | Up to 24 months | |
Secondary | Comparison of the use of social services of patients who accept or refuse the palliative care management | Patients' medical history: Use of social service... | Up to 24 months | |
Secondary | Overall survival of patients according to their acceptance or refusal of the "mixed" management | Vital status | Up to 24 months | |
Secondary | For patients having accepted the palliative support, description throughout the study of patients' compliance to palliative supportive care undertaken | Patients having performed at least 50 percent of the visits | Up to 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|